Get the tools and support you need to best manage your eczema

  • This field is for validation purposes and should be left unchanged.

Research

March 5, 2015 – Check out this NPR piece on an important new study about how eczema affects the lives of people who have it by NEA Scientific Advisory Committee member Jonathan Silverberg, MD. Data from this study demonstrates the burden of living with eczema, which helps further the case for more eczema research.

Read More


February 24, 2015 – Introduction of peanut products into the diets of infants at high risk of developing peanut allergy was safe and led to an 81 percent reduction in the subsequent development of the allergy, a clinical trial has found.

Read More


February 10, 2015 – Efficacy of topical application of human breast milk on atopic eczema healing among infants.

Read More


January 6, 2015 – For the first time, a team led by researchers at the Icahn School of Medicine at Mount Sinai has proven that atopic dermatitis, also known as eczema, is an immune-driven (autoimmune) disease.

Read More


December 15, 2014 – Patients on subcutaneous dupilumab at 300 mg once weekly showed nearly an 80% reduction from baseline in Eczema Area and Severity Index scores after 16 weeks of treatment.

Read More


November 20, 2014 – Contact Dermatitis (CD) is a term used to describe the itchy skin reaction that can occur following topical contact (and sometimes oral, or airborne) with allergy-producing chemicals in the environment.

Read More


November 5, 2014 – Seborrheic dermatitis is a common skin condition that affects the areas of the body that have a high density of oil-producing (sebaceous) glands. It affects 1 to 5 percent of the general population, and often has a chronic, relapsing course.

Read More


May 9, 2014 – The National Eczema Association (NEA) research program offers grants to established and new investigators in the field. This research ultimately benefits patients with eczema by providing much needed data to scientists, physicians and pharmaceutical companies.

Read More


April 10, 2014 – The investigational drug REGN668, a monoclonal antibody that modulates interleukins 4 and 13, significantly improved overall quality of life and pruritus in patients with severe, longstanding atopic dermatitis.

Read More


April 3, 2014 – Atopic dermatitis (AD) is a common skin disease characterized by recurrent episodes of itching. Genetic variation associated with the persistence of AD has not been described for African American subjects.

Read More